Timothy Kutzkey Ph.D

Timothy Kutzkey Ph.D General Information

Biography

Dr. Timothy Kutzkey serves as Founding Member and Chairman at Nura Bio. Dr. Kutzkey serves as Board Member at NILO Therapeutics. He serves as Founding Member and Chairman at Nura Bio. He serves as Board Member at Cajal Neuroscience. He serves as Managing Partner & Chair of Strategic Board at TCGLabs-Soleil. He serves as Board Member at Kimia Therapeutics. He serves as Board Member at Atavistik Bio. He serves as Board Member at Synthekine, Nura Bio, and Plexium. He served as Board Member at Carmot Therapeutics. He serves as Managing Partner at The Column Group. He served as Chairman at Surrozen. He serves as chairman Neurona Therapeutics. He serves as Managing Member at Ponoi Capital. He also served as Chief Executive Officer, Chief Financial Officer and Secretary at Proneurotech. He serves as Board Member at Synthekine and Nurix. He serves as a Board Member at Kallyope. He was formerly a scientist at KAI Pharmaceuticals. At KAI, hos research focused on cell assay and pharmacodynamic marker development for selective protein kinase C inhibitors. Prior to KAI, he worked at UC Berkeley as a graduate student and postdoctoral scholar in the lab of Dr. Robert Tjian. He completed his Ph.D. in 2005 on the biochemistry and genetics of long-range gene regulatory mechanisms. He was previously educated at Stanford University. He serves as Board Member at InduPro.